ANNOUNCED AS TEMPORARYNo
Decree No. 861 of 30 August 2016 expands the existing state intervention (Decree No. 1045 of 1 October 2015) to promote the local production of medicines.
Concretely, Decree 861 will:
The federal budget for 2016 foresees the allocation of 2.6 billion RUB (ca. 40.15 million USD) for the policy intervention. The subsidies are provided as part of the sub-programme "Development of medicines production" of the state program "Development of pharmaceutical and medical industry" for 2013--2020". Since Decree No. 861 plans the allocation of state subsidies in 2016 but does not allocate them, it is classified as amber.
The GTA includes state guarantees and other financial incentives that are likely to affect the restructuring and performance of firms facing international competition, whether from imports, in export markets and from foreign subsidiaries.
⚑ Please report this page in case you detect an inaccuracy in its content.